Researchers claim mystery of rare blood clots tied to COVID-19 vaccines solved, but experts urge caution – CBC
German researchers say they hope theory could help adapt adenovirus vector vaccines to increase safety
May 28, 2021
A German research team has put forward a potential solution to prevent the rare, serious blood clots caused by two leading COVID-19 vaccines, but other scientists warn it’s too early to draw conclusions about the mechanism behind the potentially deadly condition.
Even so, the researchers behind the new preprint study say they hope their theory could eventually help laboratories adapt the AstraZeneca-Oxford and Johnson & Johnson vaccines to increase safety and potentially boost global vaccination efforts.
Though uncommon, vaccine-induced immune thrombotic thrombocytopenia (VITT) is much more severe than a typical blood clot because it can cause cerebral venous sinus thrombosis (CVST), where veins that drain blood from the brain are obstructed and can potentially cause fatal bleeding.
Read more: https://www.cbc.ca/news/health/covid-19-vaccine-blood-clot-vitt-solution-research-1.6043185
